Armistice Capital »

Scilex Holding shares owned by Armistice Capital

Quarter-by-quarter ownership of Scilex Holding (SCLX) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Scilex Holding

Tip: Access up to 7 years of quarterly data

All positions including Scilex Holding held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Scilex Holding by Armistice Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.3M 66k 19.68

More positions owned by Armistice Capital

Iwm Nov5 230.0 P Listed Option Put Option (IWM)
Spy Nov5 634.0 P Listed Option Put Option (SPY)
Ptc Therapeutics Ord Equity (PTCT)
Travere Therapeutics Ord Equity (TVTX)
Supernus Pharmaceuticals Ord Equity (SUPN)
Cytk Jan7 40.0 C Listed Option Call Option (CYTK)
Madrigal Pharmaceuticals Ord Equity (MDGL)
Incyte Ord Equity (INCY)
Neurocrine Biosciences Ord Equity (NBIX)
Immunovant Ord Equity (IMVT)
Dentsply Sirona Ord Equity (XRAY)
Regeneron Pharmaceuticals Ord Equity (REGN)
Freshpet Ord Equity (FRPT)
Amazon Com Ord Equity (AMZN)
Agio Dec5 40.0 C Listed Option Call Option (AGIO)

View all positions for Armistice Capital

Top funds holding Scilex Holding

Vanguard Group
BlackRock
Geode Capital Management
Armistice Capital
State Street Corporation
Hrt Financial
UBS Group
Renaissance Technologies
Morgan Stanley
Ashton Thomas Private Wealth
Northern Trust
Donald L. Hagan
Jane Street
Quantinno Capital Management
Bnp Paribas Arbitrage, Snc

View all funds holding Scilex Holding